Essential Cell Biology 5th edition
356 CHAPTER 10 Analyzing the Structure and Function of Genesreplaced by the altered one. In this way, the function of the mutant proteincan be analyzed in the absence of the normal protein. A common wayof doing this in mice makes use of cultured mouse embryonic stem (ES)cells (discussed in Chapter 20). These cells are first subjected to targetedgene replacement before being transplanted into a developing embryo toproduce a mutant mouse, as illustrated in Figure 10–28.Using a similar strategy, the activities of both copies of a gene can beeliminated entirely, creating a “gene knockout.” To do this, one caneither introduce an inactive, mutant version of the gene into cultured EScells or delete the gene altogether. The ability to use ES cells to producesuch “knockout mice” revolutionized the study of gene function, and the(A)ES cells growingin culture(B)pregnant mousealtered versionof target geneconstructed bygeneticengineeringINTRODUCE A DNAFRAGMENT CONTAININGALTERED GENE INTOMANY CELLSLET EACH ES CELLPROLIFERATE TOFORM A COLONYINJECT ALTEREDES CELLSINTO EARLYEMBRYOISOLATE EARLYEMBRYOFigure 10–28 Targeted gene replacementin mice utilizes embryonic stem (ES)cells. (A) First, an altered version of thegene is introduced into cultured ES cells.In a few rare ES cells, the altered gene willreplace the corresponding normal genethrough homologous recombination (asdescribed in Chapter 6, pp. 220−222 andFigure 6−31). Although the procedure isoften laborious, these rare cells can beidentified and cultured to produce manydescendants, each of which carries analtered gene in place of one of its twonormal corresponding genes. (B) Next, thealtered ES cells are injected into a very earlymouse embryo; the cells are incorporatedinto the growing embryo, which thendevelops into a mouse that contains somesomatic cells (colored orange) that carry thealtered gene. Some of these mice may alsohave germ-line cells that contain the alteredgene; when bred with a normal mouse,some of the progeny of these mice willcontain the altered gene in all of their cells.Such a mouse is called a “knock-in” mouse.If two such mice are bred, one can obtainprogeny that contain two copies of thealtered gene—one on each chromosome—in all of their cells.TAKE CELLS FROM THERARE COLONY IN WHICHTHE DNA FRAGMENTHAS REPLACED ONECOPY OF THENORMAL GENEES cells with one copy of targetgene replaced by altered genesome of theseoffspring havegerm-line cellscontaining altered genethe offspring willinclude males andfemales with one copyof target genealtered in all cellsEARLY EMBRYO FORMEDPARTLY FROM ALTEREDES CELLSINTRODUCE EARLYEMBRYO INTOPSEUDOPREGNANTMOUSEBIRTHMATE WITHNORMAL MOUSEMATINGTRANSGENIC MOUSEIN WHICH BOTH COPIES OFTARGET GENE ARE ALTERED
Exploring Gene Function357(A)(B)Figure 10–29 Transgenic mice with a mutant DNA helicase show prematureaging. The helicase, encoded by the Xpd gene, is involved in both transcriptionand DNA repair. Compared with a wild-type mouse (A), a transgenic mouse thatexpresses a defective version of Xpd (B) exhibits many of the symptoms of prematureaging, including osteoporosis, emaciation, early graying, infertility, and reduced lifespan.The mutation in Xpd used here impairs the activity of the helicase and mimicsECB5 e10.36/10.29a human mutation that causes trichothiodystrophy, a disorder characterized by brittlehair, skeletal abnormalities, and a greatly reduced life expectancy. These resultssupport the hypothesis that an accumulation of DNA damage contributes to theaging process in both humans and mice. (From J. de Boer et al., Science 296:1276–1279, 2002. With permission from AAAS.)technique is now being used to systematically determine the function ofevery mouse gene (Figure 10–29).A variation of this technique can be used to produce conditional knockoutmice, in which a known gene can be disrupted more selectively—only ina particular cell type or at a certain time in development. The strategyinvolves the introduction of an enzyme, called a recombinase, that canbe directed to selectively excise—and thus disable—a gene of interest(Figure 10−30). Such conditional knockouts are useful for studying geneswith a critical function during development, because mice missing thesecrucial genes often die before birth.IN NON-TARGET TISSUES (e.g., MUSCLE), THE GENE OF INTEREST IS EXPRESSED NORMALLYCre recombinase geneLoxP sitegene of interestLoxP siteliver-specific promoterINACTIVEIN TARGET TISSUE (e.g., LIVER), THE GENE OF INTEREST IS DELETEDliver-specific promoterACTIVEGENE OFFGENE ONgene of interest removedfrom chromosome andlost as cells divideCre recombinase madeonly in liver cellsGENE ONaltered chromosomeGENE OFFprotein ofinterestCre RECOMBINASEBINDS TO LoxP SITESCre CATALYZESRECOMBINATIONBETWEEN LoxP SITESFigure 10–30 In conditional knockouts,a gene can be selectively disabled in aparticular target tissue. The approachrequires the insertion of two engineeredsegments of DNA into an animal’s germ-linecells. The first contains the gene encoding arecombinase (in this case, Cre recombinase)that is under the control of a tissue-specificpromoter. This promoter ensures thatrecombinase will be produced only in thetarget tissue. The second DNA moleculecontains the gene of interest flanked bynucleotide sequences (in this case, LoxPrecombination sites) that are recognized bythe recombinase. The mouse is engineeredso that this version of the gene of interest isthe only copy the animal has.In non-target tissues, no recombinase willbe produced and the gene of interest willbe expressed normally. In the target tissue,however, the tissue-specific promoter willbe activated, allowing the recombinase tobe produced. The enzyme will then bind tothe LoxP sites and catalyze a recombinationreaction that will excise the gene ofinterest—thus disabling it specifically in thetarget tissue.
- Page 340 and 341: 306 CHAPTER 9 How Genes and Genomes
- Page 342 and 343: 308 CHAPTER 9 How Genes and Genomes
- Page 344 and 345: 310 CHAPTER 9 How Genes and Genomes
- Page 346 and 347: 312 CHAPTER 9 How Genes and Genomes
- Page 348 and 349: 314 CHAPTER 9 How Genes and Genomes
- Page 350 and 351: 316 CHAPTER 9 How Genes and Genomes
- Page 352 and 353: 318 CHAPTER 9 How Genes and Genomes
- Page 354 and 355: 320 CHAPTER 9 How Genes and Genomes
- Page 356 and 357: 322 CHAPTER 9 How Genes and Genomes
- Page 358 and 359: 324HOW WE KNOWCOUNTING GENESHow man
- Page 360 and 361: 326 CHAPTER 9 How Genes and Genomes
- Page 362 and 363: 328 CHAPTER 9 How Genes and Genomes
- Page 364 and 365: 5′ 3′5′3′330 CHAPTER 9 How
- Page 367 and 368: CHAPTER TEN10Analyzing the Structur
- Page 369 and 370: Isolating and Cloning DNA Molecules
- Page 371 and 372: Isolating and Cloning DNA Molecules
- Page 373 and 374: Isolating and Cloning DNA Molecules
- Page 375 and 376: IIIIIIIIIIIIIDNA Cloning by PCR341D
- Page 377 and 378: DNA Cloning by PCR343HEAT TOSEPARAT
- Page 379 and 380: DNA Cloning by PCR345(A)ANALYSIS OF
- Page 381 and 382: Sequencing DNA347single-stranded DN
- Page 383 and 384: Sequencing DNA349repetitive DNAinte
- Page 385 and 386: Exploring Gene Function351each loca
- Page 387 and 388: Exploring Gene Function353(A)CONSTR
- Page 389: Exploring Gene Function355E. coli,
- Page 393 and 394: Exploring Gene Function359fused to
- Page 395 and 396: Exploring Gene Function361Figure 10
- Page 397 and 398: Questions363• DNA sequencing tech
- Page 399 and 400: CHAPTER ELEVEN11Membrane StructureA
- Page 401 and 402: ECB5 e11.05/11.05The Lipid Bilayer3
- Page 403 and 404: The Lipid Bilayer369hydrogen bondsC
- Page 405 and 406: The Lipid Bilayer371sets a lower li
- Page 407 and 408: The Lipid Bilayer373Figure 11-16 Ne
- Page 409 and 410: Membrane Proteins375TRANSPORTERS AN
- Page 411 and 412: Membrane Proteins377A Polypeptide C
- Page 413 and 414: Membrane Proteins379Figure 11-26 SD
- Page 415 and 416: Membrane Proteins381spectrin dimera
- Page 417 and 418: Membrane Proteins383apical plasmame
- Page 419 and 420: ECB5 e11.36/11.36Membrane Proteins3
- Page 421 and 422: Questions387• Most cell membranes
- Page 423 and 424: CHAPTER TWELVE12Transport Across Ce
- Page 425 and 426: Principles of Transmembrane Transpo
- Page 427 and 428: Principles of Transmembrane Transpo
- Page 429 and 430: Transporters and Their Functions395
- Page 431 and 432: Transporters and Their Functions397
- Page 433 and 434: Transporters and Their Functions399
- Page 435 and 436: Transporters and Their Functions401
- Page 437 and 438: Ion Channels and the Membrane Poten
- Page 439 and 440: Ion Channels and the Membrane Poten
Exploring Gene Function
357
(A)
(B)
Figure 10–29 Transgenic mice with a mutant DNA helicase show premature
aging. The helicase, encoded by the Xpd gene, is involved in both transcription
and DNA repair. Compared with a wild-type mouse (A), a transgenic mouse that
expresses a defective version of Xpd (B) exhibits many of the symptoms of premature
aging, including osteoporosis, emaciation, early graying, infertility, and reduced lifespan.
The mutation in Xpd used here impairs the activity of the helicase and mimics
ECB5 e10.36/10.29
a human mutation that causes trichothiodystrophy, a disorder characterized by brittle
hair, skeletal abnormalities, and a greatly reduced life expectancy. These results
support the hypothesis that an accumulation of DNA damage contributes to the
aging process in both humans and mice. (From J. de Boer et al., Science 296:1276–
1279, 2002. With permission from AAAS.)
technique is now being used to systematically determine the function of
every mouse gene (Figure 10–29).
A variation of this technique can be used to produce conditional knockout
mice, in which a known gene can be disrupted more selectively—only in
a particular cell type or at a certain time in development. The strategy
involves the introduction of an enzyme, called a recombinase, that can
be directed to selectively excise—and thus disable—a gene of interest
(Figure 10−30). Such conditional knockouts are useful for studying genes
with a critical function during development, because mice missing these
crucial genes often die before birth.
IN NON-TARGET TISSUES (e.g., MUSCLE), THE GENE OF INTEREST IS EXPRESSED NORMALLY
Cre recombinase gene
LoxP site
gene of interest
LoxP site
liver-specific promoter
INACTIVE
IN TARGET TISSUE (e.g., LIVER), THE GENE OF INTEREST IS DELETED
liver-specific promoter
ACTIVE
GENE OFF
GENE ON
gene of interest removed
from chromosome and
lost as cells divide
Cre recombinase made
only in liver cells
GENE ON
altered chromosome
GENE OFF
protein of
interest
Cre RECOMBINASE
BINDS TO LoxP SITES
Cre CATALYZES
RECOMBINATION
BETWEEN LoxP SITES
Figure 10–30 In conditional knockouts,
a gene can be selectively disabled in a
particular target tissue. The approach
requires the insertion of two engineered
segments of DNA into an animal’s germ-line
cells. The first contains the gene encoding a
recombinase (in this case, Cre recombinase)
that is under the control of a tissue-specific
promoter. This promoter ensures that
recombinase will be produced only in the
target tissue. The second DNA molecule
contains the gene of interest flanked by
nucleotide sequences (in this case, LoxP
recombination sites) that are recognized by
the recombinase. The mouse is engineered
so that this version of the gene of interest is
the only copy the animal has.
In non-target tissues, no recombinase will
be produced and the gene of interest will
be expressed normally. In the target tissue,
however, the tissue-specific promoter will
be activated, allowing the recombinase to
be produced. The enzyme will then bind to
the LoxP sites and catalyze a recombination
reaction that will excise the gene of
interest—thus disabling it specifically in the
target tissue.